Active CIDP patients also display significantly higher production of IL-17 compared to patients in remission and controls, and higher production of IFN-γ and IL-10 compared to controls, while patients in remission also expressed higher levels of IFN-γ than controls. This evidence concerns the gene IFNG and chronic inflammatory demyelinating polyradiculoneuropathy.